Company Profiles

driven by the PitchBook Platform

OptiScan Biomedical

OptiScan Biomedical
1994 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series E LATEST DEAL TYPE
$29.5M LATEST DEAL AMOUNT
22 INVESTORS
Description

Provider of instruments and sensors for automated measurement of blood glucose levels. The company is the developer of a continuous glucose monitoring device for hospital use.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
24590 Clawiter Road
Hayward, CA 94545
United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OptiScan Biomedical’s full profile, request a free trial.

OptiScan Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series E) 07-Jun-2016 $29.5M 00000 00000 Completed Profitable
10. Later Stage VC (Series D) 31-Jan-2013 000.00 00000 000.00 Completed Profitable
9. Debt - General 29-Oct-2012 00.00 00000 Completed Profitable
8. Later Stage VC (Series C) 14-Apr-2010 000.00 00000 Completed Profitable
7. Later Stage VC (Series B) 25-Sep-2008 000.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 30-Sep-2005 0000 000.00 000.00 Completed Generating Revenue
5. Senior Debt 30-Jun-2005 000 000.00 Completed Generating Revenue
4. Later Stage VC (Series D1) 25-Feb-2002 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C1) 27-Oct-1999 000 00.000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 18-Jan-1999 $2.85M $3.45M Completed Generating Revenue
1. Early Stage VC (Series A) 30-Jun-1996 $600K $600K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

OptiScan Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 000,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 58,301,795 $0.001000 8% $0.18 $0.18 1x $0.18 4.73%
Series A 805,492 $0.001000 8% $0.06 $0.06 1x $0.06 0.07%
To view this company’s complete Cap Table, request access »

OptiScan Biomedical Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Xeraya Capital Venture Capital Minority 000 0000 000000 0
Biobrit Venture Capital Minority 000 0000 000000 0
Chartline Capital Partners Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Wexford Capital PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »

OptiScan Biomedical Executive Team (6)

Name Title Board
Seat
Contact
Info
Peter Rule Chairman & Chief Executive Officer
Patrick Nugent Chief Financial Officer
Donald Webber Chief Operating Officer
Jim Causey Vice President, Research & Development

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

OptiScan Biomedical Board Members (10)

Name Representing Role Since Contact
Info
Charles Liamos MedVenture Associates Board Member 000 0000
Kenneth Abramowitz NGN Capital Board Member 000 0000
Masashi Kiyomine Mitsui Global Investment Board Observer 000 0000
Paul Mieyal Ph.D Wexford Capital Board Member 000 0000
Peter Rule OptiScan Biomedical Chairman & Chief Executive Officer 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com